Zinc Deficiency Exacerbates Lead-Induced Interleukin-2 Suppression by Regulating CREM Expression

Area of Science:

• Immunology
• Toxicology
• Cell Biology

Background:

• Lead exposure impairs T cell function and reduces interleukin-2 (IL-2) production.
• Zinc deficiency also negatively impacts T cells and is linked to decreased IL-2.
• Increased transcription factor CREM 100 kDa expression is associated with zinc deficiency and IL-2 downregulation.

Purpose of the Study:

• To investigate the molecular mechanism of lead-induced IL-2 reduction in T cells.
• To examine the role of zinc status in modulating lead's effects on T cells.
• To determine if zinc can mitigate lead toxicity in T cells.

Main Methods:

• Jurkat T cells were exposed to lead under varying zinc conditions (adequate, deficient, supplemented).
• Expression of CREM 100 kDa and production of IL-2 were measured.
• Effects of lead and zinc status on these parameters were analyzed.

Main Results:

• Lead exposure increased CREM 100 kDa expression and decreased IL-2 production.
• Zinc deficiency amplified lead's effect, causing greater CREM 100 kDa overexpression and lower IL-2 levels.
• Zinc supplementation reversed these effects, normalizing CREM 100 kDa expression and IL-2 levels.

Conclusions:

• CREM 100 kDa is identified as a molecular mediator of lead-induced IL-2 reduction in T cells.
• Zinc deficiency exacerbates lead's detrimental impact on IL-2 production.
• Adequate zinc levels are crucial for protecting T cell function against lead toxicity.